PTH-082 Comparison of Efficacy and Safety of Biosimilar Infliximab to Originator Infliximab in Children with Inflammatory Bowel Disease: Abstract PTH-082 Table 1
Muhammed, R, Wong, T, Haller, W, Protheroe, S, Whyte, L, Bremner, RVolume:
65
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2016-312388.487
Date:
June, 2016
File:
PDF, 68 KB
english, 2016